Latvia - Calcium Channel Blocking Medicine Use
Since 2014, Latvia Calcium Channel Blocking Medicine Use decreased by 3.2% year on year. With 31.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, the country was ranked number 25 among other countries in Calcium Channel Blocking Medicine Use. Latvia is overtaken by Luxembourg, which was number 24 with 33.6 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Turkey at 26.9 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Denmark lead the ranking with 92.4 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, that is +1.9% compared to 2018. Sweden, United Kingdom and Germany respectively ranked number 2, 3 and 4 in this ranking. Iceland witnessed the best average annual growth at +4.1% per year, while Austria was the worst growing country at -18.9% per year.
Loading...
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 31.50 |
| 2018 | 31.70 |
| 2017 | 33.10 |
| 2016 | 33.60 |
| 2015 | 35.70 |
How does Latvia rank in Calcium Channel Blocking Medicine Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Denmark
|
92 | 2019 | +1.9 % | +0.7 % | View data | |
| 2 |
#2
Sweden
|
91 | 2019 | +4.4 % | +3.4 % | View data | |
| 24 |
#24
Luxembourg
|
34 | 2019 | -2.6 % | -2.3 % | View data | |
| 25 |
#25
Latvia
|
32 | 2019 | -0.6 % | -3.2 % | View data | |
| 26 |
#26
Turkey
|
27 | 2019 | +0.8 % | +2.5 % | View data | |